Cancer of Liver: Clinical Trials

2 trials for Cancer of Liver, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 1, Withdrawn 1
Phase 22Unknown 1, Withdrawn 1

Follow Cancer of Liver: new trials by email Literature Review of Cancer of Liver trials Research Report on Cancer of Liver

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
PXS-5505 and Atezolizumab and Bevacizumab - Hepatocellular Carcinoma, Cancer of Liver
Phase 1 / Phase 2WithdrawnUniversity of Rochester2022-09-202023-07-13
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver
Phase 1 / Phase 2UnknownLeaf Vertical Inc.1602019-01-152018-07-31

Narrower conditions

Liver Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Colonic Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Glioblastoma (1)  ·  Multiple Myeloma (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Broader conditions

Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Liver Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Adenocarcinoma (1)  ·  Astrocytoma (1)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Blood Protein Disorders (1)  ·  Carcinoma (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Diseases (1)

Interventions

Bevacizumab (2)  ·  Bortezomib (1)  ·  Cannabidiol (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)  ·  Temozolomide (1)  ·  atezolizumab (1)

Sponsors

Leaf Vertical Inc. (1)  ·  University of Rochester (1)

Countries

United States (2)

Top investigators

Nabeel Badri (1)  ·  Sarah F Katta, DO (1)